O'Neill S K, Bolger G T
Division of Basic Medical Sciences, Memorial University of Newfoundland, St. John's, Canada.
Brain Res Bull. 1989 Apr;22(4):611-6. doi: 10.1016/0361-9230(89)90078-6.
The impairment of rotarod ability and the convulsive activity of phencyclidine (PCP) and MK-801 were compared in male CD-1 mice. The putative interaction between nifedipine and PCP and MK-801 on these behavioral measurements was also quantitated and compared. MK-801 produced a dose dependent inhibition of rotarod ability with an ED50 of 0.5 mg/kg. Nifedipine potentiated the impairment of rotarod ability by MK-801. Both PCP and MK-801 produced convulsive behavior in mice which was characterized by jumping and wild running fits; the CD50 for MK-801 was 1.3 mg/kg. Nifedipine dose dependently inhibited the convulsions associated with MK-801 and PCP. PCP but not MK-801 increased [3H]nitrendipine binding to dihydropyridine (DHP) binding sites on mouse brain membranes. MK-801 blocked the effects of PCP on [3H]nitrendipine binding. These findings suggest that MK-801 is a potent PCP-like drug which interacts with nifedipine and neuronal DHP binding sites. Nifedipine's reduction of the hyperactivity and convulsions elicited by MK-801 may be of importance in the eventual development of MK-801 as an antiischaemic and anticonvulsant drug.
在雄性CD-1小鼠中比较了转棒能力的损害以及苯环利定(PCP)和MK-801的惊厥活性。还对硝苯地平与PCP和MK-801在这些行为测量上的假定相互作用进行了定量和比较。MK-801对转棒能力产生剂量依赖性抑制,半数有效剂量(ED50)为0.5 mg/kg。硝苯地平增强了MK-801对转棒能力的损害。PCP和MK-801均在小鼠中产生惊厥行为,其特征为跳跃和狂奔发作;MK-801的半数惊厥剂量(CD50)为1.3 mg/kg。硝苯地平剂量依赖性地抑制与MK-801和PCP相关的惊厥。PCP而非MK-801增加了[3H]尼群地平与小鼠脑膜上二氢吡啶(DHP)结合位点的结合。MK-801阻断了PCP对[3H]尼群地平结合的影响。这些发现表明,MK-801是一种强效的PCP样药物,可与硝苯地平和神经元DHP结合位点相互作用。硝苯地平降低MK-801引起的多动和惊厥,这可能对MK-801最终发展成为抗缺血和抗惊厥药物具有重要意义。